Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 2Phase 3 1

Status

Completed 19Recruiting 5Terminated 4Unknown 3Withdrawn 2No longer available 2Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 4NETWORK 1

Study Type

Interventional 5

Sponsor

Cancer Type

Sarcoma 5

Conditions

Sarcoma 5Leiomyosarcoma 2Liposarcoma, Myxoid 1Liposarcoma 1Leiomyosarcoma Uterus 1Chondrosarcoma, Mesenchymal 1

Interventions

Doxorubicin 15pembrolizumab 12Cyclophosphamide 9Surgical Procedures, Operative 8Gemcitabine 8Blood Specimen Collection 8Ifosfamide 7Surveys and Questionnaires 6Nivolumab 6Trabectedin 5Radiotherapy 5Magnetic Resonance Spectroscopy 5Drug Therapy 5fludarabine 4Temozolomide 4Specimen Handling 4Radiation Dose Hypofractionation 4Biopsy 4selinexor 3pazopanib 3liposomal doxorubicin 3cabozantinib 3atezolizumab 3anlotinib 3Radiation 3Observation 3Docetaxel 3Dacarbazine 3trastuzumab deruxtecan 2toripalimab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Recruiting × Sarcoma × Trabectedin × Clear all
NCT04383119 2026-03-25

ISG-ARTICLE

Italian Sarcoma Group

Phase 2 Recruiting
100 enrolled
Sarcoma

Sarcoma

NCT05597917 2025-04-04

TRABTRAP

Universität Münster

Phase 3 Recruiting
126 enrolled
Sarcoma

Sarcoma

NCT03138161 2025-02-24

SAINT:Trabectedin, Ipilimumab and Nivolumab for Previously Treated Advanced Soft Tissue Sarcoma

Sarcoma Oncology Research Center, LLC

Phase 1/2 Recruiting
250 enrolled
Sarcoma

Sarcoma

NCT03886311 2025-02-24

TNT

Sarcoma Oncology Research Center, LLC

Phase 2 Recruiting
200 enrolled
Sarcoma

Sarcoma

NCT02275286 2023-05-31

TRASTS

Grupo Espanol de Investigacion en Sarcomas

Phase 1/2 Recruiting
199 enrolled
Sarcoma

Leiomyosarcoma, Liposarcoma, Sarcoma, Liposarcoma, Myxoid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡